Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Hitting Home Runs & Grand Slams, Not Loud Outs
- RTI: Do Stocks Tank When QE Ends?
- AWS 5/23: Is the Market Over-Reacting?
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Aggressive Growth Stocks
- Who Wants to Keep "Too Big to Fail" Alive?
- Debt-Ceiling Alarm Bell Tolls
- Avoid These 3 Eurozone ETFs This Summer
- RTI: When Will We Finally See a Pullback?
- Top Stocks with Big Potential Catch-Up Moves
- PFP 5/23: Do No Harm
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/22/2013
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 9.31% |
| SONIC FOUNDR | SOFO | 7.77% |
| VELTI PLC OR | VELT | 7.58% |
| TRI TECH HOL | TRIT | 6.62% |
| A M R CP | AAMRQ | 4.52% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Dental laser maker BIOLASE Technology ( ) has inked a sales and marketing pact with Kirkland, Washington-based leading dental education group Seattle Study Club (“SSC”).
SSC, a global organization of dentists, is among the most advanced dental education groups. Dentists and dental specialists, who are the members of the group, are dedicated to maintaining the highest level of knowledge in dentistry and share new techniques/technology and means to better serve their patients.
Under the agreement, BIOLASE will gain access to SSC's 8,000 members and over 350 study clubs globally to educate them on how to make the best use of the company’s products and services.
The program will involve a number of activities including the demonstration of BIOLASE's laser technology at SSC's national symposiums, advertising in SSC publications, cooperative web marketing and direct promotions to members through SSC's newsletters, webcasts and journal. The partnership is among a series of new marketing initiatives which BIOLASE plans to introduce this year.
BIOLASE develops and markets lasers and related products for applications in medicine and dentistry. Its key products are dental laser systems that perform a broad spectrum of dental procedures, including cosmetic and complex surgical applications.
The company’s sales more than doubled year over year in third-quarter 2011 to $13.1 million. The healthy growth was mainly attributable to its exit from an exclusive distribution arrangement with Henry Schein ( HSIC - Snapshot Report ) and return to a direct sales and multi-distributor model.
The company’s WaterLase all-tissue dental lasers accounted for roughly 63% of total sales in the quarter with the Waterlase iPlus laser contributing the most. BIOLASE, during the third quarter, won regulatory approvals in Canada and Russia to market the WaterLase iPlus laser.
Moreover, the company clinched regulatory approval for the device in South Korea in November 2011. Waterlase iPlus was launched in the U.S. in early 2011.
Read the full Snapshot Report on HSIC